Analgetic Dose
Showing 9976 - 10000 of >10,000
Obstructive Sleep Apnea, Down Syndrome Trial in Tucson (Atomoxetine and Oxybutynin (ato-oxy))
Not yet recruiting
- Obstructive Sleep Apnea
- Down Syndrome
- Atomoxetine and Oxybutynin (ato-oxy)
-
Tucson, ArizonaUniversity of Arizona
Jun 26, 2023
Bendamustine, Multiple Myeloma Trial in Shenyang (Bendamustine)
Recruiting
- Bendamustine
- Multiple Myeloma
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Aug 7, 2021
COPD Trial in United States (YPL-001 80 mg, YPL-001 160 mg, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- YPL-001 80 mg
- +2 more
-
Birmingham, Alabama
- +3 more
Jun 24, 2021
Gaucher's Disease Trial in Beijing, Chengdu, Guangzhou (Cerezyme® / Imiglucerase)
Recruiting
- Gaucher's Disease
- Cerezyme® / Imiglucerase
-
Beijing, China
- +4 more
Jul 12, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Bellinzona, Chur, St. Gallen (Docetaxel micellar)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Docetaxel micellar
-
Bellinzona, Switzerland
- +2 more
Nov 7, 2022
Stem Cell Transplantation Trial in Porto Alegre (Cycle ergometer, Strength Training - elastic band and shin guards, Cycle
Enrolling by invitation
- Stem Cell Transplantation
- Cycle ergometer
- +2 more
-
Porto Alegre, RS, BrazilSanta Casa de Misericórdia de Porto Alegre
Nov 10, 2023
Colorectal Cancer Trial in Monroe (Colorectal Screen rates with implementation of evidence-based intervention)
Enrolling by invitation
- Colorectal Cancer
- Colorectal Screen rates with implementation of evidence-based intervention
-
Monroe, IndianaMonroe Family Medicine (Adams Medical Group Monroe)
Nov 17, 2023
Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)
Completed
- Sars-CoV2
- COVID
- Enoxaparin
- Prophylactic/Intermediate Dose Enoxaparin
-
Newark, New Jersey
- +5 more
Nov 17, 2021
Opioid Use Disorder Trial in Lexington (Oxycodone, Remifentanil)
Recruiting
- Opioid Use Disorder
-
Lexington, KentuckyLaboratory of Human Behavioral Pharmacology
Feb 10, 2022
Labor Pain Trial in Istanbul (Dolantin, Paracetamol)
Recruiting
- Labor Pain
-
Istanbul, Bağcılar, TurkeyIstanbul Medipol University
Aug 10, 2022
Basal Cell Carcinoma Trial in West Palm Beach, New York (Doxorubicin-containing MNA, Placebo-containing MNA)
Recruiting
- Basal Cell Carcinoma
- Doxorubicin-containing MNA
- Placebo-containing MNA
-
West Palm Beach, Florida
- +1 more
Aug 10, 2022
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute
Active, not recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +2 more
-
Columbus, Ohio
- +2 more
Aug 10, 2022
Urinary Bladder, Neurogenic, Multiple Sclerosis Trial in Lausanne (VESIcare 10Mg Tablet, Botox 100 UNT Injection)
Recruiting
- Urinary Bladder, Neurogenic
- Multiple Sclerosis
- VESIcare 10Mg Tablet
- Botox 100 UNT Injection
-
Lausanne, SwitzerlandCentre Hospitalier Universitaire Vaudois
Feb 4, 2022
Lupus Nephritis Trial in Worldwide (BI 655064 dose 1, BI 655064 dose 2, BI 655064 dose 3)
Completed
- Lupus Nephritis
- BI 655064 dose 1
- +3 more
-
Los Angeles, California
- +73 more
Jun 18, 2021
Inflammation;Muscle(S), Oxidative Stress Injury, Permeability; Increased Trial in Poznan (black chokeberry (Aronia melanocarpa),
Completed
- Inflammation;Muscle(S)
- +2 more
- black chokeberry (Aronia melanocarpa)
- Placebo
-
Poznań, PolandUniversity of Physical Education in Poznan
Nov 13, 2023
Patients With Prostate Cancer Trial in Toronto (MRI Guided Needles to deliver HDR Brachytherapy)
Recruiting
- Patients With Prostate Cancer
- MRI Guided Needles to deliver HDR Brachytherapy
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Oct 4, 2021
Fabry Disease Trial in Worldwide (PRX-102 (pegunigalsidase alfa), agalsidase beta)
Completed
- Fabry Disease
- PRX-102 (pegunigalsidase alfa)
- agalsidase beta
-
Birmingham, Alabama
- +28 more
Oct 12, 2022
Healthy Volunteers Trial in Baltimore (BIIB122 (DNL151), [14C] BIIB122 ([14C] DNL151))
Completed
- Healthy Volunteers
- BIIB122 (DNL151)
- [14C] BIIB122 ([14C] DNL151)
-
Baltimore, MarylandPharmaron CPC
Nov 9, 2021
Episodic Cluster Headache Trial in Worldwide (Fremanezumab, Placebo)
Chronic Inflammatory Demyelinating Polyneuropathy Trial (Cyclophosphamide)
Withdrawn
- Chronic Inflammatory Demyelinating Polyneuropathy
- (no location specified)
Nov 2, 2021
Neuroendocrine Tumors Trial in Uppsala (AdVince)
Recruiting
- Neuroendocrine Tumors
-
Uppsala, SwedenEndocrine Oncology Clinic, Uppsala University Hospital
Nov 4, 2021
Healthy Trial in Goiânia (empagliflozin/metformin, Jardiance®, Glifage®)
Completed
- Healthy
- empagliflozin/metformin
- +2 more
-
Goiânia, BrazilInstituto de Ciências Farmacêuticas de Estudos e Pesquisas - ICF
Oct 29, 2021
Recurrent AL Amyloidosis, Refractory AL Amyloidosis Trial in Duarte, Boston, Columbus (Bone Marrow Aspiration and Biopsy,
Recruiting
- Recurrent AL Amyloidosis
- Refractory AL Amyloidosis
- Biospecimen Collection
- +9 more
-
Duarte, California
- +10 more
Jan 19, 2023